Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jul;16(5):556-572.
doi: 10.1177/1747493020961926. Epub 2020 Oct 6.

A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study

Affiliations
Randomized Controlled Trial

A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study

Erin Godecke et al. Int J Stroke. 2021 Jul.

Abstract

Background: Effectiveness of early intensive aphasia rehabilitation after stroke is unknown. The Very Early Rehabilitation for SpEech trial (VERSE) aimed to determine whether intensive aphasia therapy, beginning within 14 days after stroke, improved communication recovery compared to usual care.

Methods: Prospective, randomized, single-blinded trial conducted at 17 acute-care hospitals across Australia/New Zealand from 2014 to 2018. Participants with aphasia following acute stroke were randomized to receive usual care (direct usual care aphasia therapy), or one of two higher intensity regimens (20 sessions of either non-prescribed (usual care-plus or prescribed (VERSE) direct aphasia therapy). The primary outcome was improvement of communication on the Western Aphasia Battery-Revised Aphasia Quotient (AQ) at 12 weeks after stroke. Our pre-planned intention to treat analysis combined high intensity groups for the primary outcome.

Findings: Among 13,654 acute stroke patients screened, 25% (3477) had aphasia, of whom 25% (866) were eligible and 246 randomized to usual care (n = 81; 33%), usual care-plus (n = 82; 33%) or VERSE (n = 83; 34%). At 12 weeks after stroke, the primary outcome was assessed in 217 participants (88%); 14 had died, 9 had withdrawn, and 6 were too unwell for assessment. Communication recovery was 50.3% (95% CI 45.7-54.8) in the high intensity group (n = 147) and 52.1% (95% CI 46.1-58.1) in the usual care group (n = 70; difference -1.8, 95% CI -8.7-5.0). There was no difference between groups in non-fatal or fatal adverse events (p = 0.72).

Interpretation: Early, intensive aphasia therapy did not improve communication recovery within 12 weeks post stroke compared to usual care.

Keywords: Aphasia; communication; early; rehabilitation; stroke; therapy fidelity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CONSORT study flow diagram.
Figure 2.
Figure 2.
WAB-R (AQ) Baseline, 12-, and 26-week outcomes with 95% confidence intervals.

References

    1. Brady MC, Kelly H, Godwin J, Enderby P and Campbell P. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016: (6). Art. No.: CD000425. DOI: 10.1002/14651858.CD000425.pub4. - PMC - PubMed
    1. Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012; 11: 369–380. - PMC - PubMed
    1. Nouwens F, de Lau LML, Visch-Brink EG, et al. on behalf of the RATS-3 investigators. Efficacy of early cognitive-linguistic treatment for aphasia due to stroke: a randomised controlled trial (Rotterdam Aphasia Therapy Study-3). Euro Stroke J 2017; 2: 126–136. - PMC - PubMed
    1. Laska AC, Kahan T, Hellblom A, Murray V, von Arbin M. A randomized controlled trial on very early speech and language therapy in patients with acute stroke and aphasia. Cerebrovasc Dis Extra 2011; 1: 66–74. - PMC - PubMed
    1. Godecke E, Hird K, Lalor EE, Rai T, Phillips M. Very early post-stroke aphasia therapy: a pilot randomised controlled efficacy trial. Int J Stroke 2012; 7: 635–644. - PubMed

Publication types